News for Second Sight Medical Products, Inc. (EYES)

Vivani Medical, Inc. (NASDAQ: VANI) (”œVivani” or the ”œCompany”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting dru

Vivani Medical's chief business officer buys $1.92k in company stock

/PRNewswire/ -- DelveInsight's Nerve Repair and Regeneration Market Insights report provides the current and forecast market analysis, individual leading nerve...

Manufacturers in the bionic eye market are earning more due to rapid innovations & developments in bionic eye technologies. Acquire Fact.MR’s market report...

Vivani Medical, Inc. , an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company received notice from the National Institutes of Health ... | April 4, 2023

Vivani Medical, Inc. , a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment of patients with type 2 diabetes,... | March 31, 2023

Vivani Medical Files for Proposed IPO of its Subsidiary Cortigent

Vivani Medical, Inc. , an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, today announced the filing of a Registration Statement on Form S-1... | March 21, 2023

Cortigent (CRGT), which has developed a neurostimulation device for restoring vision in people with profound blindness, has filed to raise $17M through an IPO. Read more here.

Pixium Vision welcomes judgment by Paris Commercial Court against Second Sight Medical Products Court finds Second Sight Medical Products breached 2021 contractual obligations to Pixium... | December 28, 2022

Penny stocks to buy according to analysts in December 2022.

The border has been closed to most Americans since March 2020, when the Covid-19 pandemic prompted travel restrictions. Read More -> Los Angeles Imposes New Mask Mandate Los Angeles...

UBS Global Wealth Management advises buying the Canadian dollar against the Japanese yen, targeting a level of 91 in CAD/JPY and placing a stop loss at 85. CAD/JPY is last up 0.4% at 87.9750. We...

Mr. Biden and Democratic leaders said that advancing the deal on transportation, water and broadband infrastructure will hinge on the passage of more elements of Mr. Biden's $4 trillion economic...

Apricus Biosciences Inc is a pharmaceutical company. It focuses on the development of product candidates in the areas of urology and rheumatology. The company h...

Analysts Rate These Penny Stocks A Buy Right Now The thought of making money with penny stocks is always the favored goal, right? It’s simple, just buy then ...

Toward the end of trading Wednesday, the Dow traded up 2.02% to 31,005.69 while the NASDAQ rose 0.61% to 12,897.65. The S&P also rose, gaining 1.46% to ...

Midway through trading Wednesday, the Dow traded up 1.63% to 30,886.85 while the NASDAQ rose 0.53% to 12,886.46. The S&P also rose, gaining 1.17% to ...